A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.
@article{Pannee2013ASR, title={A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.}, author={Josef Pannee and E. Portelius and M. Oppermann and Alan R. Atkins and M. Hornshaw and I. Zegers and Peter H{\"o}jrup and L. Minthon and O. Hansson and H. Zetterberg and K. Blennow and J. Gobom}, journal={Journal of Alzheimer's disease : JAD}, year={2013}, volume={33 4}, pages={ 1021-32 } }
Cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) are increasingly used in research centers, clinical trials, and clinical settings. However, their broad-scale use is hampered by lack of standardization across analytical platforms and by interference from binding of amyloid-β (Aβ) to matrix proteins as well as self-aggregation. Here, we report on a matrix effect-resistant method for the measurement of the AD-associated 42 amino acid species of Aβ (Aβ42), together with Aβ40 and A… Expand
93 Citations
Mass spectrometric quantification of amyloid-beta in cerebrospinal fluid and plasma
- Chemistry
- 2015
- 1
- PDF
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.
- Chemistry, Medicine
- Clinical chemistry
- 2014
- 102
- PDF
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
- Medicine
- Clinica chimica acta; international journal of clinical chemistry
- 2017
- 75
- PDF
Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.
- Chemistry, Medicine
- Journal of Alzheimer's disease : JAD
- 2014
- 75
An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.
- Chemistry, Medicine
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
- 2017
- 5
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method.
- Medicine
- Clinical chemistry
- 2020
- 4
Multiple reaction monitoring assay based on conventional liquid chromatography and electrospray ionization for simultaneous monitoring of multiple cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- Chemistry, Medicine
- Archives of pharmacal research
- 2016
- 3
A Review on MS-Based Blood Biomarkers for Alzheimer’s Disease
- Medicine
- Neurology and Therapy
- 2019
- 12
- Highly Influenced
- PDF
Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications
- Medicine
- Clinical chemistry and laboratory medicine
- 2015
- 20
- Highly Influenced
- PDF
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- Medicine
- Clinical chemistry and laboratory medicine
- 2016
- 49
- PDF
References
SHOWING 1-10 OF 41 REFERENCES
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
- Medicine
- Biomarkers in medicine
- 2012
- 79
A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species.
- Chemistry, Medicine
- Bioanalysis
- 2011
- 27
Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
- Medicine
- Clinical chemistry and laboratory medicine
- 2010
- 87
Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.
- Chemistry, Medicine
- Analytical biochemistry
- 2011
- 89
- Highly Influential
Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid
- Medicine
- International journal of Alzheimer's disease
- 2010
- 225
- PDF
Prediction of Alzheimer’s Disease Using the CSF Aβ42/Aβ40 Ratio in Patients with Mild Cognitive Impairment
- Psychology, Medicine
- Dementia and Geriatric Cognitive Disorders
- 2007
- 251
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
- Chemistry, Medicine
- Rapid communications in mass spectrometry : RCM
- 2006
- 135
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- Biology, Medicine
- Nature Biotechnology
- 2009
- 891
- PDF
Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.
- Chemistry, Medicine
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
- 2009
- 305
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- Medicine
- Nature Reviews Neurology
- 2010
- 1,409